MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer

Cancer Letters

Volumn 342, Issue 1, 2014, Pages 121-129

  Zhang, Fang ^a   Yang, Zhiping ^a,b   Cao, Minjun ^a   Xu, Yinsheng ^a   Li, Jintao ^a   Chen, Xuebin ^a   Gao, Zhi ^c   Xin, Jing ^a   Zhou, Shaomei ^a   Zhou, Zhixiang ^a   Yang, Yishu ^a   Sheng, Wang ^a   Zeng, Yi ^a  

^a BEIJING UNIVERSITY OF TECHNOLOGY   (China)

^b Affiliated Hospital of University of North China   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; MiR 203; MiR 21; Ran; Tumor suppressor

Indexed keywords

MICRORNA; MICRORNA 203; MICRORNA 21; RAN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME; UPREGULATION;

ESOPHAGEAL CANCER; MIR-203; MIR-21; RAN; TUMOR SUPPRESSOR;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RAN GTP-BINDING PROTEIN; RNA INTERFERENCE; TUMOR BURDEN;

EID: 84887615440     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.08.037     Document Type: Article

References (32)

1. DeMeester S.R. Epidemiology and biology of esophageal cancer. Gastrointest. Cancer Res. 2009, 3:S2-5.
2. Shimada Y., Imamura M., Shibagaki I., Tanaka H., Miyahara T., Kato M., Ishizaki K. Genetic alterations in patients with esophageal cancer with short-and long-term survival rates after curative esophagectomy. Ann. Surg. 1997, 226:162-168.
3. Guo Y., Chen Z., Zhang L., Zhou F., Shi S., Feng X., Li B., Meng X., Ma X., Luo M., Shao K., Li N., Qiu B., Mitchelson K., Cheng J., He J. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008, 68:26-33.
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
6. Feber A., Xi L., Luketich J.D., Pennathur A., Landreneau R.J., Wu M., Swanson S.J., Godfrey T.E., Litle V.R. MicroRNA expression profiles of esophageal cancer. J. Thor. Cardiovasc. Surg. 2008, 135:255-260.
7. Hu Y., Correa A.M., Hoque A., Guan B., Ye F., Huang J., Swisher S.G., Wu T.T., Ajani J.A., Xu X.C. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 2010, 128:132-143.
8. Li X., Wainscott C., Xi Y. MicroRNA provides insight into understanding esophageal cancer. Thor. Cancer 2011, 2:134-142.
9. Luthra R., Singh R., Luthra M., Li Y., Hannah C., Romans A., Barkoh B., Chen S., Ensor J., Maru D. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008, 27:6667-6678.
10. Kan T., Sato F., Ito T., Matsumura N., David S., Cheng Y., Agarwal R., Paun B.C., Jin Z., Olaru A.V. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136:1689-1700.
11. Lee K.H., Goan Y.G., Hsiao M., Lee C.H., Jian S.H., Lin J.T., Chen Y.L., Lu P.J. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp. Cell. Res. 2009, 315:2529-2538.
12. Fassan M., Volinia S., Palatini J., Pizzi M., Baffa R., De Bernard M., Battaglia G., Parente P., Croce C.M., Zaninotto G. MicroRNA expression profiling in human Barrett's carcinogenesis. Int. J. Cancer 2011, 129:1661-1670.
13. Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., Abraham R., Romans A.M., Yao H., Luthra M.G., Anandasabapathy S. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol. 2009, 174:1940-1948.
14. Ogawa R., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Katada T., Harata K., Tanaka T., Fujii Y. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med. Mol. Morphol. 2009, 42:102-109.
15. Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., Chiyomaru T., Enokida H., Nakagawa M., Matsubara H. MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:2804-2814.
16. Wu B.L., Xu L.Y., Du Z.P., Liao L.D., Zhang H.F., Huang Q., Fang G.Q., Li E.M. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J. Gastroenterol. 2011, 17:79-88.
17. Mathé E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., Schetter A.J., Braun R., Reimers M., Kumamoto K., Hughes D. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009, 15:6192-6200.
18. Yi R., Poy M.N., Stoffel M., Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229.
19. Yuan Y., Zeng Z.-Y., Liu X.-H., Gong D.-J., Tao J., Cheng H.-Z., Huang S.-D. MicroRNA-203 inhibits cell proliferation by repressing δNp63 expression in human esophageal squamous cell carcinoma. BMC Cancer 2011, 11:57-67.
20. Laganà A., Forte S., Russo F., Giugno R., Pulvirenti A., Ferro A. Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints. J RNAi Gene Silencing 2010, 6:379-385.
21. Veksler-Lublinsky I., Shemer-Avni Y., Kedem K., Ziv-Ukelson M. Gene bi-targeting by viral and human miRNAs. BMC Bioinformatics 2010, 11:249.
22. Krichevsky A.M., Gabriely G. MiR-21: a small multi-faceted RNA. J. Cell. Mol. Med. 2008, 13:39-53.
23. Hiyoshi Y., Kamohara H., Karashima R., Sato N., Imamura Y., Nagai Y., Yoshida N., Toyama E., Hayashi N., Watanabe M. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin. Cancer Res. 2009, 15:1915-1922.
24. Chiang Y., Song Y., Wang Z., Chen Y., Yue Z., Xu H., Xing C., Liu Z. Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J. Gastrointest. Surg. 2011, 15:63-70.
25. Schetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L.W., Au G.K.H. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
26. Shiiba M., Uzawa K., Tanzawa H. MicroRNAs in head and neck squamous cell carcinoma. Cancers 2010, 2:653-669.
27. Bueno M.J., Pérez de Castro I., Gómez de Cedrón M., Santos J., Calin G.A., Cigudosa Juan C., Croce C.M., Fernández-Piqueras J., Malumbres M. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogeneexpression. Cancer Cell 2008, 13:496-506.
28. Viticchiè G., Lena A.M., Latina A., Formosa A., Gregersen L.H., Lund A.H., Bernardini S., Mauriello A., Miano R., Spagnoli L.G. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011, 10:1121-1131.
29. Viticchie G., Lena A.M., Cianfarani F., Odorisio T., Annicchiarico-Petruzzelli M., Melino G., Candi E. MicroRNA-203 contributes to skin re-epithelialization. Cell Death Dis. 2012, 3:e435.
30. Barrès V., Ouellet V., Lafontaine J., Tonin P.N., Provencher D.M., Mes-Masson A.M. An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol. Cancer 2010, 9:272-282.
31. Kurisetty V., Johnston P., Johnston N., Erwin P., Crowe P., Fernig D., Campbell F., Anderson I., Rudland P., El-Tanani M. RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 2008, 27:7139-7149.
32. Abe H., Kamai T., Shirataki H., Oyama T., Arai K., Yoshida K. High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. Int. J. Cancer 2008, 122:2391-2397.